Pathogenic Dendritic Cells In Human Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$370,983.00
Summary
The cost of treating end stage kidney disease in Australia is more than a billion dollars per year. Kidney disease is associated with an influx of inflammatory cells. However, current therapeutics fail to target this process due to our poor understanding of inflammatory immune cells in disease progression. This project will investigate the biology of immune cells in human kidney disease. I believe that this study will inform more accurate diagnoses and improved treatments for patients.